Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

529) $(13,214) $(51,979) ======= ======= ======== ======== ======== Basic and diluted net loss per common share $(0.05) $(0.07) $(0.16) $(0.17) $(1.14) ====== ====== ====== ====== ====== Shares used in computing basic and diluted net loss per share 76,436 76,363 76,388 76,350 45,444 ====== ====== ====== ====== ======
                                    Bionovo, Inc.
                            (A Development Stage Company)
                             Consolidated Balance Sheets
                        (in thousands, except share amounts)

                                                  September 30,   December 31,
                                                          2009           2008
                                                          ----           ----
                                                      (unaudited)
          ASSETS
    Current assets:
      Cash and cash equivalents                          $2,252        $3,270
      Short-term investments                                 -         10,292
      Receivables                                            56           126
      Prepaid expenses and other current assets             651           805
                                                            ---           ---
        Total current assets                              2,959        14,493
    Property and equipment, net                           6,141         6,938
    Other assets and patent pending, net                  1,349         1,073
                                                          -----         -----
        Total assets                                    $10,449       $22,504
                                                        =======       =======

          LIABILITIES AND SHAREHOLDERS' EQUITY

    Cur
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... and segments the concerned market with analysis and ... $261.8 million in 2014, and is estimated to ... of 19.3% from 2014 to 2019. ... Simulation Market for an analysis of industry trends ...
(Date:6/2/2015)... , June 2, 2015 BioDelivery Sciences International, Inc. ... the presentation by Dr. Mark A. Sirgo , President ... 2:30 PM Eastern time. Jefferies 2015 Global Healthcare ... Hyatt, New York City , NY ... accessed at www.bdsi.com .  For those who are not ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:6/2/2015)... Prussia, PA (PRWEB) June 02, 2015 ... Outsourcing solutions for health plans in the Medicare Advantage, ... participation as a sponsor and exhibitor at AHIP’s Institute ... America’s Health Insurance Plans. The conference will be held ... exhibition booth, #1303, will offer opportunities for attendees to ...
(Date:6/2/2015)... Dallas, TX, USA (PRWEB) June 02, 2015 ... and microsystems, is deploying its growth strategy to benefit ... on BioMEMS: “In Yole Développement’s May 2015 Status of ... market will grow sharply and reach $6.6B in 2020,” ... at Yole Développement . , The analyst adds ...
(Date:6/2/2015)... MedPro Healthcare Staffing, the leading provider of temporary ... the worldwide release of the MedPro Top Jobs app, ... find best jobs that fit their needs. , According ... 10 job seekers report they’re likely to use a ... Top Jobs app gives its users 24/7 mobile access ...
(Date:6/2/2015)... June 02, 2015 Claflin Medical ... has announced the acquisition of RSI Equipment, ... effective May 29th, 2015. , With CME’s recent merger ... latest acquisition joins three premier organizations which specialize in ... and healthcare facilities. By combining forces, they now cover ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Marketing. Mr. Smith will be responsible ... the awareness and visibility of MAP’s core message, products ... was the Marketing Manager at Cottonwood Financial in Irving, ...
Breaking Medicine News(10 mins):Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2
... understanding of the evolution and spread of viruses like H5N1, ... a consortium, where all// information about the avian influenza will ... on Sharing Avian Influenza Data (GISAID) was announced in ... that was signed by 70 scientists and health officials. Dr. ...
... a vaccine against pneumococcal disease will be introduced for the ... 50 babies and small children a year and prevnt// illness ... national childhood immunisation programme. all babies will be vaccinated against ... months,from Sept.4. Apart from that, in a catch-up programme, infants ...
... analytical capabilities of high-tech laboratory tools, like computers, their ... they have// developed a second generation "lab on a ... first time rapidly and reliably sequences all mitochondrial DNA, ... Diagnostics. Mitochondria which are the energy-producing organelles in cells, ...
... tools such as computers with greater analytical capacities are ... generation "lab on a silicon chip" called the MitoChip ... mitochondrial DNA quickly and reliably. Their report will be ... Molecular Diagnostics. ,The mitochondria have their own ...
... a coordinated global plan, especially in developing countries to ... HIV/AIDS-related cases. ,57 countries, mostly in sub-Saharan ... facing acute shortage. Over 4 million workers are needed ... Train, Retain’ is an essential part of its effort ...
... latest example of growing online interaction between Britain and ... hour for online tuition on various subjects from teachers ... have been receiving such one-to-one tuition using Internet telephony ... employs teachers who work in shifts. ,While ...
Cached Medicine News:Health News:Global avian flu database 2Health News:Global avian flu database 3Health News:Global avian flu database 4Health News:Immunisation programme to include vaccine against Pneumococcal disease 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 3Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 4Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:British Pupils Opt for Online Tuition from India 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,160-2) ... assistance. Color: colour-coded ...
... These 3mL PYREX volumetric pipets ... tolerances in accordance with ASTM ... pipet is individually serialized and ... Identification and Capacity, traceable to ...
... disposable lever action skin stapler ... that is designed to provide ... work from your normal vantage ... available in four configurations: 35 ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: